3clpro (BPS Bioscience)
95
Structured Review
BPS Bioscience
3clpro
3clpro, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 95/100, based on 57 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/3clpro/3CL+Protease%2C+Untagged+(SARS-CoV-2)+Assay+Kit/pmc12854628-147-1-5
Average 95 stars, based on 57 article reviews
3clpro, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 95/100, based on 57 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/3clpro/3CL+Protease%2C+Untagged+(SARS-CoV-2)+Assay+Kit/pmc12854628-147-1-5
Average 95 stars, based on 57 article reviews
3clpro - by Bioz Stars,
2026-09
95/100 stars
Images
Related Articles
Inhibition:Article Title: Method and combination for the suppression of COVID-19 virus Article Snippet: .. A Enzymatic Assay:Article Title: Identification of SARS-CoV-2 M pro inhibitors containing P1' 4-fluorobenzothiazole moiety highly active against SARS-CoV-2. Article Snippet: .. SARS-CoV-2 Mpro/3CLpro and human cysteine protease enzyme assay The Activity Assay:Article Title: Identification of SARS-CoV-2 M pro inhibitors containing P1' 4-fluorobenzothiazole moiety highly active against SARS-CoV-2. Article Snippet: .. SARS-CoV-2 Mpro/3CLpro and human cysteine protease enzyme assay The Article Title: Dual-Reporter System for Real-Time Monitoring of SARS-CoV-2 Main Protease Activity in Live Cells Enables Identification of an Allosteric Inhibition Path. Article Snippet: The SARS-CoV-2 pandemic is an ongoing threat to global health, and the continuing emergence of contagious variants highlights the urgent need for additional antiviral therapy to attenuate COVID-19 disease.. The SARS-CoV-2 main protease (3CLpro) presents an attractive target for such therapy due to its high sequence conservation and key role in the viral life cycle.. In this study, we designed a fluorescent−luminescent cell-based reporter for the detection and quantification of 3CLpro intracellular activity. Article Title: Impact of Single Halogen Atom Substitutions on Antiviral Profile of Inhibitors Targeting SARS-CoV‑2 Main Protease Article Snippet: .. The Article Title: Identification of SARS-CoV-2 M pro inhibitors containing P1’ 4-fluorobenzothiazole moiety highly active against SARS-CoV-2 Article Snippet: .. The In Vitro:Article Title: Dual-Reporter System for Real-Time Monitoring of SARS-CoV-2 Main Protease Activity in Live Cells Enables Identification of an Allosteric Inhibition Path. Article Snippet: The SARS-CoV-2 pandemic is an ongoing threat to global health, and the continuing emergence of contagious variants highlights the urgent need for additional antiviral therapy to attenuate COVID-19 disease.. The SARS-CoV-2 main protease (3CLpro) presents an attractive target for such therapy due to its high sequence conservation and key role in the viral life cycle.. In this study, we designed a fluorescent−luminescent cell-based reporter for the detection and quantification of 3CLpro intracellular activity. Incubation:Article Title: Dual-Reporter System for Real-Time Monitoring of SARS-CoV-2 Main Protease Activity in Live Cells Enables Identification of an Allosteric Inhibition Path. Article Snippet: The SARS-CoV-2 pandemic is an ongoing threat to global health, and the continuing emergence of contagious variants highlights the urgent need for additional antiviral therapy to attenuate COVID-19 disease.. The SARS-CoV-2 main protease (3CLpro) presents an attractive target for such therapy due to its high sequence conservation and key role in the viral life cycle.. In this study, we designed a fluorescent−luminescent cell-based reporter for the detection and quantification of 3CLpro intracellular activity. |